Press Releases

Home > Press Releases

Press Releases (Page 17)

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Hut 8, Ventyx, and Anavex and Encourages Investors to Contact the Firm

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Hut 8 Corp. (NASDAQ: HUT), Ventyx Biosciences, Inc. (NASDAQ: VTYX), and Anavex Life Sciences Corp. (NASDAQ: AVXL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional... ❯❯❯

AUTODESK ALERT: Bragar Eagel & Squire, P.C. is Investigating Autodesk, Inc. on Behalf of Autodesk Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK) on behalf of Autodesk stockholders. Our investigation concerns whether Autodesk has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the... ❯❯❯

AXTI ALERT: Bragar Eagel & Squire, P.C. is Investigating AXT, Inc. on Behalf of AXTI Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against AXT, Inc. (“AXTI” or the “Company”) (NASDAQ: AXTI) on behalf of AXTI stockholders. Our investigation concerns whether AXTI has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On April... ❯❯❯

HIRERIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against HireRight Holdings Corporation and Encourages Investors to Contact the Firm

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against HireRight Holdings Corporation (“HireRight” or the “Company”) (NYSE: HRT) in the United States District Court for the Middle District of Tennessee on behalf of all persons and entities who purchased or otherwise acquired HireRight securities... ❯❯❯

ZYMEWORKS ALERT: Bragar Eagel & Squire, P.C. is Investigating Zymeworks Inc. on Behalf of Zymeworks Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME) on behalf of Zymeworks stockholders. Our investigation concerns whether Zymeworks has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in... ❯❯❯

AXSOME ALERT: Bragar Eagel & Squire, P.C. is Investigating Axsome Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Axsome Therapeutics, Inc. (NASDAQ: AXSM) on behalf of long-term stockholders following a class action complaint that was filed against Axsome on May 13, 2022 with a Class Period from December 30, 2019 to April 22, 2022. Our investigation concerns whether the board of... ❯❯❯

ZEVRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Zevra Therapeutics, Inc. on Behalf of Zevra Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Zevra Therapeutics, Inc. (“Zevra” or the “Company”) (NASDAQ: ZVRA) on behalf of Zevra stockholders. Our investigation concerns whether Zevra has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the... ❯❯❯

ADM ALERT: Bragar Eagel & Squire, P.C. is Investigating Archer-Daniels-Midland Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Archer-Daniels-Midland Company (NYSE: ADM) on behalf of long-term stockholders following a class action complaint that was filed against ADM on January 24, 2024 with a Class Period from April 30, 2020 to January 22, 2024. Our investigation concerns whether the board... ❯❯❯

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Charles River Laboratories International, Inc. (NYSE: CRL) on behalf of long-term stockholders following a class action complaint that was filed against Charles River on May 19, 2023 with a Class Period from May 5, 2020 to February 21, 2023. Our investigation concerns... ❯❯❯

OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 02, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN) on behalf of Ocugen stockholders. Our investigation concerns whether Ocugen has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. ... ❯❯❯